Holen Sie sich die Stockscreener-App
26.13
1.59%
0.41
Handel nachbörslich:
26.13
Schlusskurs vom Vortag:
$25.72
Offen:
$25.92
24-Stunden-Volumen:
508.04K
Relative Volume:
0.65
Marktkapitalisierung:
$11.39B
Einnahmen:
$5.64B
Nettoeinkommen (Verlust:
$305.00M
KGV:
37.44
EPS:
0.698
Netto-Cashflow:
-
1W Leistung:
+1.67%
1M Leistung:
+1.59%
6M Leistung:
-14.94%
1J Leistung:
-8.57%
1-Tages-Spanne:
$25.85
$26.17
1-Wochen-Bereich:
$25.54
$26.17
52-Wochen-Spanne:
$23.65
$31.72
Smith Nephew Plc Adr Stock (SNN) Company Profile
Firmenname
Smith Nephew Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SNN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
26.13 | 11.39B | 5.64B | 305.00M | 0 | 0.698 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-06 | Herabstufung | Berenberg | Buy → Hold |
| 2024-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-24 | Eingeleitet | Deutsche Bank | Buy |
| 2024-06-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-11-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2023-11-03 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-10-31 | Hochstufung | HSBC Securities | Hold → Buy |
| 2023-10-13 | Eingeleitet | Stifel | Hold |
| 2023-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2023-04-27 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-04-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | Eingeleitet | Citigroup | Buy |
| 2022-11-28 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-07-28 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-04 | Hochstufung | Redburn | Sell → Neutral |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | Eingeleitet | Barclays | Overweight |
| 2020-07-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-11-21 | Eingeleitet | Citigroup | Buy |
| 2019-11-12 | Eingeleitet | Bernstein | Outperform |
| 2019-07-23 | Hochstufung | Berenberg | Hold → Buy |
| 2019-02-08 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-12-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | Bestätigt | Canaccord Genuity | Buy |
| 2018-01-25 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-12-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-27 | Herabstufung | Goldman | Buy → Neutral |
| 2017-01-19 | Eingeleitet | HSBC Securities | Hold |
| 2016-12-08 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | Herabstufung | Berenberg | Buy → Hold |
| 2016-02-26 | Eingeleitet | Cantor Fitzgerald | Hold |
Alle ansehen
Smith Nephew Plc Adr Aktie (SNN) Neueste Nachrichten
SNN (Smith & Nephew plc ADR) may reap gains as insiders became active recently - Knox Daily
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
Goldman Downgrades Riskified Ltd (RSKD) to a Sell from a Neutral - Knox Daily
Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes - GlobeNewswire Inc.
Smith+Nephew appoints new Non-Executive Director - Investing.com
Endoprosthesis Market Size to Surpass USD 60.39 Billion by 2032 at a CAGR of 9.86% - GlobeNewswire Inc.
Weekly Upgrades and Downgrades - InvestorPlace
Smith & Nephew Earnings: Quarterly Sales Suggest China Weakness Into 2025 - Morningstar
Smith & Nephew Sees Challenges in China Market - Morningstar
Smith & Nephew lowers 2024 outlook on China headwinds - Investing.com
Smith+Nephew, JointVue partner on ultrasound-based surgical planning for surgical robotics - Mass Device
Analytical Overview: Smith & Nephew plc ADR (SNN)’s Ratios Tell a Financial Story - The Dwinnex
Smith+Nephew launches new Legion knee system - Mass Device
South Korea Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
The Best Healthcare Stocks to Buy - Morningstar
Smith & Nephew Aligns Director Fees with Shares - TipRanks
China Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Japan Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Smith+Nephew announces first Catalystem hip system procedures - Mass Device
Ratios in Focus: Analyzing Smith & Nephew plc ADR (SNN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Smith+Nephew launches Total Ankle patient-matched guides - Mass Device
Upward Trajectory: Smith & Nephew plc ADR (SNN) Posts a Slidee, Closing at 30.67 - The Dwinnex
Saudi Arabia Antimicrobial Wound Care Dressings Market Size & Outlook, 2030 - Grand View Research
Medical Robotics Surgery Market to Grow at CAGR of 10.82% through 2033 - GlobeNewswire Inc.
InfuSystem, Smith+Nephew ink wound therapy distro deal - Mass Device
Smith+Nephew shares jump on strong H1 results and reaffirmed guidance - Investing.com UK
Smith+Nephew wins FDA nod for hip system compatible with Cori surgical robot - Mass Device
Europe First Aid Market Size & Outlook, 2023-2030 - Grand View Research
Smith & Nephew stock gains on Cevian stake (NYSE:SNN) - Seeking Alpha
Smith+Nephew launches pre-op planning tech for surgical robotics - Mass Device
Healthcare Sector - Morningstar
Here’s Why You Should Invest in Smith & Nephew plc (SNN) - Yahoo Finance
Smith+Nephew rolls out new chronic wound treatment tech - Mass Device
7 Robotic Surgery Stocks to Buy for the Future of Healthcare - Yahoo Finance
Smith+Nephew sales are up 7% as 12-point plan progresses - Mass Device
Smith+Nephew kicks off Aetos shoulder system launch at AAOS - Mass Device
Smith+Nephew unveils expanded sports medicine portfolio - Mass Device
Study backs Smith+Nephew Regeneten bioinductive rotator cuff implant - Mass Device
Smith+Nephew launches hip arthroplasty system in India - Mass Device
SNN: Add This Top Equipment Stock to Your Portfolio for a Strong Week Ahead - StockNews.com
Smith+Nephew unveils handheld digital tensioning device for robotic knee surgery - Mass Device
Zimmer Biomet Holdings Inc. stock falls Thursday, underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms market despite losses on the day - MarketWatch
Zimmer Biomet Holdings Inc. stock falls Friday, underperforms market - MarketWatch
8 Newly Undervalued 5-Star Stocks - Morningstar
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock falls Tuesday, underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Finanzdaten der Smith Nephew Plc Adr-Aktie (SNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.16%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):